Résumé
Aims: To compare clinical, psychological, education and social variables in emerging adults (aged 18–30 years) with Type 1 diabetes with their adult counterparts aged >30 years. Methods: A single assessment multinational sample was surveyed as part of the larger second Diabetes Attitudes, Wishes and Needs (DAWN2) study. Participants completed a series of surveys incorporating demographic as well as clinical questions (comorbidities, hypoglycaemia) and validated self-report scales concerning psychosocial (health impact, quality of life, beliefs and attitudes, self-management behaviours, healthcare experience and family support) and diabetes education factors. Results: Emerging adults differed from adults aged >30 years with regard to a number of psychosocial variables. Emerging adults reported better overall quality of life, social support and support from their healthcare team compared with adults aged >30 years of age; however, emerging adults experienced greater diabetes-specific distress and were less engaged in self-management. Diabetes education was related to a number of indicators, while experience of discrimination was harmful, but these impacts did not differ between emerging adults and adults aged >30 years. An analysis of geographical regions suggested that emerging adults in North America and Europe had better well-being than older adults, while the opposite was observed in Asia. Conclusions: Emerging adults, particularly those in the later phase (ages 25–30 years) are especially at risk in terms of diabetes-specific distress. There is a need for novel interventions to meet the needs of these vulnerable emerging adults more effectively.
Langue d'origine | English |
---|---|
Pages (de-à) | 203-213 |
Nombre de pages | 11 |
Journal | Diabetic Medicine |
Volume | 35 |
Numéro de publication | 2 |
DOI | |
Statut de publication | Published - févr. 2018 |
Note bibliographique
Funding Information:The DAWN2 study was a global partnership of established organizations, including the International Diabetes Federation, the International Alliance of Patients’ Organizations, the Steno Diabetes Centre, and Novo Nordisk. We would like to thank the International Publication Planning Committee, and Mark Peyrot and Soren Skovlund in particular, for allowing us access to the data and for their support of these analyses.
Publisher Copyright:
© 2017 Diabetes UK
ASJC Scopus Subject Areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Endocrinology